Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 11Prostatic Neoplasms 5Ovarian Neoplasms 5Neoplasms 5Stomach Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Leukemia, Myeloid, Acute 2Fallopian Tube Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Vomiting 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Thyroid Neoplasms 1Thromboembolism 1Thrombocytopenia 1Stomatitis 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Scleroderma, Localized 1Psoriasis 1Postoperative Hemorrhage 1Pleural Effusion 1Peritoneal Neoplasms 1Pancreatic Cyst 1Pain, Postoperative 1Pain 1

Interventions

Dexamethasone 21Palonosetron 16Aprepitant 14Ondansetron 12Calcium Dobesilate 11Granisetron 7fosaprepitant 6dexamethasone acetate 5Doxorubicin 4netupitant, palosentron drug combination 3dexamethasone 21-phosphate 3Olanzapine 3Diphenhydramine 3Cyclophosphamide 3Cisplatin 3netupitant 2Vincristine 2Therapeutics 2Surveys and Questionnaires 2Sugars 2Radiotherapy 2Metoclopramide 2Mesna 2Lorazepam 2Ifosfamide 2Fluorouracil 2Dronabinol 2rolapitant 1phenazine 1ginger extract 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Vomiting × Saline Solution × Clear all
NCT01432015 2017-03-28

Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting

Gynecologic Oncology Associates

Phase 4 Completed
20 enrolled 5 charts
Gynecologic

Ovarian Neoplasms, Uterine Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡